Pharmaceutical Lead Generation With Co-Marketing Campaigns

Pharmaceutical lead generation with co-marketing campaigns is a way to find and qualify healthcare leads through shared outreach. It can include webinars, disease education, congress participation, and shared landing pages with another organization. Co-marketing may help both brands reach the same audience with less duplicated effort. The approach works best when roles, compliance steps, and measurement plans are clear before launch.

One useful starting point is to review a pharmaceutical lead generation agency that supports co-marketing planning and execution, such as pharmaceutical lead generation agency services from AtOnce. Many teams also set up lead capture, follow-up, and reporting processes early to avoid gaps after events.

What “co-marketing” means in pharmaceutical lead generation

Co-marketing partners and typical roles

In pharma, co-marketing usually means two companies agree to market together for a shared goal. The partners may be biopharma, device makers, digital health groups, CROs, patient support programs, or specialty distributors.

Each partner typically owns specific tasks. One brand may lead the clinical topic, while the other leads audience outreach, creative, or operations. A clear RACI (who does what) often reduces delays during medical-legal review.

Common co-marketing channels

Co-marketing can use many channels that support both awareness and lead capture.

• Events: conferences, symposia, advisory boards, and booth-based programs
• Webinars: disease education sessions with joint speakers
• Content: joint white papers, slide decks, and disease state resources
• Digital campaigns: co-branded paid media, newsletters, and programmatic audience targeting
• Landing pages: shared forms, gated downloads, and event registration pages
• Email follow-up: coordinated sequences for registrants and non-attendees

Lead generation goals that co-marketing can support

Co-marketing is often used to reach specific healthcare segments, such as specialists in a disease area. It can also support education and engagement that later drives conversions.

Typical goals include:

• Collecting compliant opt-in registrations for a webinar or educational session
• Generating qualified HCP leads for sales or medical affairs workflows
• Building list growth through shared audiences and sign-up flows
• Re-engaging existing contacts with new education and product information

Planning a co-marketing campaign for pharmaceutical lead generation

Pick the target audience and the “lead” definition early

Lead generation begins with a clear definition of what counts as a lead. In pharma, lead definitions usually include identity, role, and eligibility rules.

A campaign may target:

• HCPs (by specialty, region, and practice type)
• Institutions (hospital, clinic, research center)
• Patient support stakeholders (depending on jurisdiction and compliance)

Before launch, teams can document the exact form fields needed, the minimum data required, and how each field is used for routing and qualification.

Select partner fit and align on the medical narrative

Partner selection can reduce compliance and positioning risk. Often, partners align on the disease area, clinical topic, and education scope. If the campaign includes product claims, roles for review and approvals should be clear.

For many co-marketing campaigns, the safest path is to structure messaging around education first. Product-specific content can be handled within agreed guardrails during medical-legal review.

Build the campaign workplan and compliance timeline

Pharmaceutical co-marketing often involves more review steps than a single-brand campaign. A practical workplan includes drafts, review checkpoints, and sign-off dates for:

• Landing pages and forms
• Webinar scripts, abstracts, and slide decks
• Speaker materials and publication plans
• Email templates and follow-up communications
• HCP outreach language used in ads or partner channels

Teams can set early internal deadlines based on the slowest step, especially medical-legal review and privacy/legal checks.

Designing the lead capture and qualification flow

Choose the right registration and landing page structure

Co-marketing campaigns usually use a shared landing page to reduce friction and keep data in one place. The landing page can include the value of the session, clear registration steps, and compliant consent language.

Common best practices include:

• Using a single form source of truth across partner channels
• Collecting only needed fields to support qualification
• Tracking source fields (which partner, which channel, which campaign)
• Ensuring consistent privacy and consent wording across partner websites

Define lead routing, ownership, and handoff rules

Lead routing should be planned before the first registration. Otherwise, leads may sit in a queue or be handled by the wrong team.

Teams can set rules such as:

• Which team owns the lead after capture (commercial, medical affairs, or partner)
• How leads are enriched (specialty, geography, or organization type)
• What triggers sales engagement versus education-only follow-up
• How duplicate leads are handled if both partners market the same audience

For many programs, a CRM integration supports automated assignment and campaign attribution. If automation is not possible, a manual process with clear SLAs may still work.

Qualification tiers for webinar and event leads

Not every registrant becomes a sales-ready lead right away. Many co-marketing teams use qualification tiers based on engagement level and data completeness.

• Registered: submitted form with verified eligibility fields
• Attended: attended live or met minimum viewing time for a webinar
• Engaged content: downloaded materials or clicked follow-up content
• Sales-ready: meets agreed criteria for outreach by role and timing

These tiers can be aligned with internal compliance rules and the approved follow-up plan.

Co-marketing execution: webinars, events, and content

Webinar co-marketing that supports compliant lead capture

Webinars are a common tool for pharmaceutical lead generation because they combine education and capture in one flow. Co-hosting with a partner can broaden the audience and support joint speaker credibility.

A typical webinar plan includes:

1. Confirm the topic, learning objectives, and speaker list
2. Draft run-of-show and slide outline for joint review
3. Set the registration page and consent language
4. Publish reminder emails and partner channel announcements
5. Plan post-webinar assets and follow-up messages

After the session, lead handling may include segmentation and timing rules based on engagement. A helpful resource for post-event follow-up is how to nurture pharmaceutical leads after events.

Conference and congress co-marketing programs

At conferences, co-marketing can include shared advisory sessions, co-branded education in the booth area, or joint appointments for eligible HCPs. Even when the booth is separate, coordinated messaging can keep the lead experience consistent.

Operations details matter:

• Badge scanning rules and consent capture (where required)
• Staff scripts for qualifying questions
• Printed or digital QR flows to a unified landing page
• Same-day lead import into CRM and suppression rules

Joint content that converts without overstepping claims

Joint content can support lead nurturing when it is focused on education and approved scope. Examples include a disease state overview, treatment journey map (within allowed claims), or an outcomes education guide created with agreed language.

To keep lead capture effective, many teams gate the best assets while offering simpler resources without gating. The content plan can match the qualification tiers defined earlier.

When using testimonials or speaker quotes, it can be important to follow medical and legal review. A related guide is how to use testimonials in pharmaceutical lead generation.

Measurement and attribution for co-marketing campaigns

Set KPIs for awareness, capture, and follow-up

Co-marketing measurement can be split into steps. Each step may need different KPIs to show progress without mixing unrelated metrics.

• Awareness: impressions, attendance interest, and partner channel reach
• Capture: registrations, form completion rate, and lead data completeness
• Engagement: webinar attendance rate, on-demand views, and content downloads
• Sales/medical impact: routed lead counts, meetings booked, or approved follow-up actions

Plan attribution across partner channels

Attribution can be hard when multiple partners drive traffic. A practical approach is to use consistent source tracking fields in forms and CRM.

Useful attribution elements can include:

• UTM parameters and campaign IDs
• Partner name and channel source in the form
• Unique registration links per partner channel when possible
• Suppression rules to prevent overcounting duplicate leads

Report results in a shared scorecard

Co-marketing partners often need a shared scorecard to align on what success means. The scorecard can include activity counts, lead quality indicators, and next-step decisions for future campaigns.

Reporting should be specific and grounded in agreed data sources, such as CRM exports and event platforms. If partners use different systems, mapping rules should be documented before the campaign ends.

Compliance, privacy, and medical-legal review in co-marketing

Medical-legal review steps for co-branded assets

Co-marketing can add complexity to approvals because each partner’s content and claims may be reviewed. A simple way to reduce risk is to standardize templates and checklists for:

• Slides and speaker scripts
• Booth signage and digital banners
• Landing pages, emails, and follow-up messages
• FAQ documents and downloadable resources

For teams that want a deeper view of how review processes affect lead generation, medical-legal review impact on lead generation can help explain where delays and rework often occur.

Privacy and consent for lead capture

Privacy rules vary by region. In many places, consent and notice language must match how data will be used. Co-marketing campaigns should avoid mismatched consent between partner channels and shared landing pages.

Common controls include:

• Clear purpose statements for data use
• Role-based routing aligned with consent
• Data retention timelines and deletion requests process
• Secure data transfer between partners and vendors

Speaker and promotional compliance

Speakers and promotional materials may require separate review steps. If co-marketing includes joint speakers, agendas and slides can be reviewed to ensure claims stay within approved language.

It can help to keep a shared “content boundary” document that lists what is allowed, what needs additional review, and what must be avoided.

Lead nurturing after co-marketing campaigns

Post-event follow-up sequences by lead tier

Post-event nurturing often determines whether leads become active. A co-marketing campaign can capture interest, but follow-up actions often decide engagement depth.

A common approach is to send different messages based on engagement tier:

• Registered but not attended: replays, reminders of the key topics, and a next education step
• Attended: a recap plus a relevant resource tied to the disease area
• Engaged: deeper content, office hours, or a medical education pathway

Many teams also coordinate partner follow-up so that messaging is consistent across the same leads. This supports a clearer experience and reduces duplicate contacts.

Managing handoffs between partner marketing and internal teams

When two brands share lead capture, handoff is a key step. Clear instructions for CRM updates, ownership, and suppression rules help avoid outreach conflicts.

Practical handoff tasks can include:

• Ensuring campaign attribution fields are filled
• Marking communication consent status
• Aligning follow-up timing with internal schedules
• Providing call notes and event context where relevant

A focused guide on what to do after events is available here: how to nurture pharmaceutical leads after events.

Common pitfalls in pharmaceutical lead generation with co-marketing

Unclear ownership and delayed approvals

Many co-marketing issues come from unclear ownership. If roles for content, compliance, and lead routing are not documented, deadlines can slip.

Working practice: confirm RACI, review owners, and final approvers before production starts.

Inconsistent lead capture and duplicate leads

When multiple landing pages or forms are used without shared tracking rules, attribution and lead quality can suffer. Duplicate leads can also create outreach conflicts.

Working practice: use one primary landing page or one unified CRM intake logic with suppression rules.

Messaging that does not match the education scope

Co-marketing can drift into unclear claims if the narrative is not controlled. This is especially risky when partners use different internal messaging guidelines.

Working practice: align on a shared message framework and keep product claims inside approved formats.

How to choose partners for future co-marketing campaigns

Evaluate partner audience overlap and alignment

Partner fit can be assessed by how well the audiences match the target healthcare segment. Alignment on the disease area and education scope matters more than simple channel reach.

Useful evaluation questions include:

• Does the partner audience match the intended specialty or institution type?
• Can both partners support compliant education content?
• Can lead routing and CRM intake be integrated with agreed rules?

Use pilot campaigns to test lead quality

Many teams run a smaller pilot before a larger co-marketing program. A pilot can test registration flow, medical-legal review timing, and lead routing performance.

After a pilot, a shared review can identify what to change in landing pages, follow-up sequences, and partner messaging.

Conclusion

Pharmaceutical lead generation with co-marketing campaigns can support both audience growth and qualified lead capture when planning is tight. Clear lead definitions, coordinated landing pages, and a shared workplan for medical-legal review can reduce delays. Measurement can be strengthened by shared source tracking and a common scorecard across partners. After the campaign, lead nurturing and clean handoffs often determine whether co-marketing delivers continued engagement.